Pharmamarketeer

Blood test could predict treatment effectiveness months earlier in breast cancer

A team of scientists at The Institute of Cancer Research in London and The Royal Marsden NHS Foundation Trust have developed a blood test which could analyse whether a breast cancer patient is responding to the treatment palbociclib in two to three weeks, potentially reaching a judgement months earlier than current testing allows.

Reageer

Medhc-fases-banner
Advertentie(s)